Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism


Author index

Page Path
Katrine Hygum  (Hygum K) 1 Article
Bone Metabolism
Skeletal Fragility in Type 2 Diabetes Mellitus
Jakob Starup-Linde, Katrine Hygum, Bente Lomholt Langdahl
Endocrinol Metab. 2018;33(3):339-351.   Published online September 18, 2018
  • 5,136 View
  • 91 Download
  • 20 Citations
AbstractAbstract PDFPubReader   ePub   

Type 2 diabetes (T2D) is associated with an increased risk of fracture, which has been reported in several epidemiological studies. However, bone mineral density in T2D is increased and underestimates the fracture risk. Common risk factors for fracture do not fully explain the increased fracture risk observed in patients with T2D. We propose that the pathogenesis of increased fracture risk in T2D is due to low bone turnover caused by osteocyte dysfunction resulting in bone microcracks and fractures. Increased levels of sclerostin may mediate the low bone turnover and may be a novel marker of increased fracture risk, although further research is needed. An impaired incretin response in T2D may also affect bone turnover. Accumulation of advanced glycosylation endproducts may also impair bone strength. Concerning antidiabetic medication, the glitazones are detrimental to bone health and associated with increased fracture risk, and the sulphonylureas may increase fracture risk by causing hypoglycemia. So far, the results on the effect of other antidiabetics are ambiguous. No specific guideline for the management of bone disease in T2D is available and current evidence on the effects of antiosteoporotic medication in T2D is sparse. The aim of this review is to collate current evidence of the pathogenesis, detection and treatment of diabetic bone disease.


Citations to this article as recorded by  
  • Bone parameters in T1D and T2D assessed by DXA and HR-pQCT – A cross-sectional study: The DIAFALL study
    Nicklas Højgaard-hessellund Rasmussen, Jakob Dal, Annika Vestergaard Kvist, Joop P. van den Bergh, Morten Hasselstrøm Jensen, Peter Vestergaard
    Bone.2023; 172: 116753.     CrossRef
  • Effects of a Lifestyle Intervention on Bone Turnover in Persons with Type 2 Diabetes: A Post Hoc Analysis of the U-TURN Trial
    Medicine & Science in Sports & Exercise.2022; 54(1): 38.     CrossRef
  • The Effects of 12-Weeks Whey Protein Supplements on Markers of Bone Turnover in Adults With Abdominal Obesity – A Post Hoc Analysis
    Rasmus Fuglsang-Nielsen, Elin Rakvaag, Peter Vestergaard, Kjeld Hermansen, Søren Gregersen, Jakob Starup-Linde
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?
    Nicklas H. Rasmussen, Peter Vestergaard
    Best Practice & Research Clinical Rheumatology.2022; 36(3): 101779.     CrossRef
  • Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India
    J. Paul, V. Devarapalli, J. T. Johnson, K. E. Cherian, F. K. Jebasingh, H. S. Asha, N. Kapoor, N. Thomas, T. V. Paul
    Osteoporosis International.2021; 32(8): 1585.     CrossRef
  • Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes
    Praveer Sihota, Ram Naresh Yadav, Ruban Dhaliwal, Jagadeesh Chandra Bose, Vandana Dhiman, Deepak Neradi, Shailesh Karn, Sidhartha Sharma, Sameer Aggarwal, Vijay G Goni, Vishwajeet Mehandia, Deepak Vashishth, Sanjay Kumar Bhadada, Navin Kumar
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(5): e2271.     CrossRef
  • The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions
    J.P. van den Bergh, P. Szulc, A.M. Cheung, M. Bouxsein, K. Engelke, R. Chapurlat
    Osteoporosis International.2021; 32(8): 1465.     CrossRef
  • Characteristics of bone metabolism in postmenopausal women with newly diagnosed type 2 diabetes mellitus
    Huijuan Li, Yuhua Wen, Peipei Liu, Liya Zhang, Xiaoya Zhang, Yichen Liu, Bin Ma, Haidong Kuang, Jianxin Wang, Lige Song
    Clinical Endocrinology.2021; 95(3): 430.     CrossRef
  • Associations between markers of glucose metabolism and bone measures among diabetic and non-diabetic adults
    Kelly Virecoulon Giudici, Natasha Aparecida Grande de França, Bárbara Santarosa Emo Peters, Regina Mara Fisberg, Lígia Araújo Martini
    Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1247.     CrossRef
  • Diabetes increases the risk of bone fractures in patients on kidney replacement therapy: A Danish national cohort study
    Sabina Chaudhary Hauge, Bo Abrahamsen, Gunnar Gislason, Jonas Bjerring Olesen, Kristine Hommel, Ditte Hansen
    Bone.2021; 153: 116158.     CrossRef
  • Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
    Jeonghoon Ha, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Seung Hyun Ko, Moo Il Kang, Sung Dae Moon, Ki-Hyun Baek
    Endocrinology and Metabolism.2021; 36(4): 895.     CrossRef
  • Can fingernail quality predict bone damage in Type 2 diabetes mellitus? a pilot study
    Praveer Sihota, Rimesh Pal, Ram Naresh Yadav, Deepak Neradi, Shailesh Karn, Vijay G. Goni, Siddhartha Sharma, Vishwajeet Mehandia, Sanjay Kumar Bhadada, Navin Kumar, Sudhaker D. Rao, Subburaman Mohan
    PLOS ONE.2021; 16(9): e0257955.     CrossRef
  • Do patients with diabetes have an increased risk of impaired fracture healing? A systematic review and meta‐analysis
    Zi‐chuan Ding, Wei‐nan Zeng, Xiao Rong, Zhi‐min Liang, Zong‐ke Zhou
    ANZ Journal of Surgery.2020; 90(7-8): 1259.     CrossRef
  • Association between abdominal obesity and fragility fractures among elderly Israeli women
    Orit Ofir, Assaf Buch, Vanessa Rouach, Rebecca Goldsmith, Naftali Stern, Efrat Monsonego-Ornan
    Aging Clinical and Experimental Research.2020; 32(8): 1459.     CrossRef
  • Diabetes and fractures: new evidence of atypical femoral fractures?
    N.H. Rasmussen, J. Dal, F. de Vries, J.P. van den Bergh, M.H. Jensen, P. Vestergaard
    Osteoporosis International.2020; 31(3): 447.     CrossRef
  • Association of glycaemic variables with trabecular bone score in post‐menopausal women with type 2 diabetes mellitus
    B. Depczynski, P. Y. Liew, C. White
    Diabetic Medicine.2020; 37(9): 1545.     CrossRef
  • Understanding Bone Disease in Patients with Diabetic Kidney Disease: a Narrative Review
    Sabina Chaudhary Hauge, Morten Frost, Ditte Hansen
    Current Osteoporosis Reports.2020; 18(6): 727.     CrossRef
  • Falls and Fractures in Diabetes—More than Bone Fragility
    Nicklas Højgaard Rasmussen, Jakob Dal
    Current Osteoporosis Reports.2019; 17(3): 147.     CrossRef
  • Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
    Lin Jiating, Ji Buyun, Zhang Yinchang
    BioMed Research International.2019; 2019: 1.     CrossRef
  • An update on therapies for the treatment of diabetes-induced osteoporosis
    Sahar Mohsin, May MYH Baniyas, Reem SMH AlDarmaki, Kornélia Tekes, Huba Kalász, Ernest A. Adeghate
    Expert Opinion on Biological Therapy.2019; 19(9): 937.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism